Commentary: Isolated stem cells - Patentable as cultural artifacts?

Stem Cells

Volumn 25, Issue 6, 2007, Pages 1507-1510

  Hansson, Mats G ^a   Helgesson, Gert ^a   Wessman, Richard ^b   Jaenisch, Rudolf ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Ethics; Patent; Stem cells

Indexed keywords

ARTIFACT; BLASTOCYST; CELL ISOLATION; EMBRYO; EMBRYONIC STEM CELL; EPIGENETICS; HUMAN; HUMAN CELL; MORALITY; PATENT; REVIEW; TISSUE CULTURE;

ADAPTATION, BIOLOGICAL; CELL CULTURE TECHNIQUES; CELL SEPARATION; COMMERCE; CULTURE; EMBRYO RESEARCH; EPIGENESIS, GENETIC; EUROPE; HUMAN BODY; HUMANS; JUDICIAL ROLE; PATENTS; STEM CELLS;

EID: 34547117593     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0684     Document Type: Review

References (31)

1. Vogel G. European patents. Stem cell claims face legal hurdles. Science 2004;305:1887.
2. Gallagher K. Battles loom over basic patent on stem cells. Milwaukee Journal Sentinel. November 13, 2004. Available at: http://www.jsonline.com/ story/index.aspx?id=274984. Accessed March 7, 2007.
3. The European Group on Ethics in Science and New Technologies. Opinion on the ethical aspects of patenting inventions involving human stem cells. Presented to: The European Commission. May 7, 2002.
4. The European Commission. Development and implications of patent law in the field of biotechnology and genetic engineering. Presented to: The European Council and Parliament. COM 312. July 14, 2005; Brussels, Belgium.
5. Jaenisch R. Human cloning - the science and ethics of nuclear transplantation. N Engl J Med 2004;351:2787-2791.
6. Humpherys D, Eggan K, Akutsu H et al. Epigenetic instability in ES cells and cloned mice. Science 2001;293:95-97.
7. Ferguson-Smith AC, Surani MA. Imprinting and the epigenetic asymmetry between parental genomes. Science 2001;293:1086-1089.
8. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA. Epigenetic status of human embryonic stem cells. Nat Genet 2005;37:585-587.
9. Conti L, Pollard SM, Gorba T et al. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 10.1371/journal.pbio. 0030283.
10. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
11. Doherty AS, Mann MR, Tremblay KD et al. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod 2000;62:1526-1535.
12. Mann MR, Lee SS, Doherty AS et al. Selective loss of imprinting in the placenta following preimplantation development in culture. Development 2004;131:3727-3735.
13. DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 2003;72:156-160.
14. Murrell A, Heeson S, Cooper WN et al. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: Interaction between genotype and epigenotype. Hum Mol Genet 2004;13:247-255.
15. Niemitz EL, Feinberg AP. Epigenetics and assisted reproductive technology: A call for investigation. Am J Hum Genet 2004;74:599-609.
16. Reik W, Dean W. DNA methylation and mammalian epigenetics. Electrophoresis 2001;22:2838-2843.
17. Ramsahoye BH, Biniszkiewicz D, Lyko F et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A 2000;97:5237-5242.
18. Laurie G. Patenting stem cells of human origin. Eur Intellect Prop Rev 2004;26:59-66.
19. Kamage A, Heider J. The blurry biotech line. IP Law and Business. 2005. Available at: http://www.ipww.com. Accessed March 7, 2007.
20. Taymor KS, Thomas Scott C, Greely HT. The paths around stem cell intellectual property. Nat Biotechnol 2006;24:411-413.
21. Porter G, Denning C, Plomer A et al. The patentability of human embryonic stem cells in Europe. Nat Biotechnol 2006;24:653-655.
22. Walters LR. Human embryonic stem cell research: An intercultural perspective. Kennedy Inst Ethics J 2004;14:3-38.
23. Plomer, Aurora. Stem cell patents: European patent law and ethics report. The University of Nottingham. July 28, 2006. Available at: http://www. nottingham.ac.uk/law/StemCellProject/project.report.pdf. Accessed March 7, 2007.
24. Gesetz zum Schutz von Embryonen (EschG). German Federal Ministry of Justice. December 13, 1990. Available at: http://bundesrecht.juris.de/eschg/ index.html. Accessed March 7, 2007.
25. Gesetz zur Sicherstellung des Embryonenschutzes im Zusammenhang mit Einfuhr und Verwendung menschlicher embryonaler Stammzellen (StZG). German Federal Ministry of Justice. June 28, 2002. Available at: http://bundesrecht. juris.de/stzg/index.html. Accessed March 7, 2007.
26. Loring JF, Campbell C. Science and law. Intellectual property and human embryonic stem cell research. Science 2006;311:1716-1717.
27. Esmond RW, Schwartzman RA. Stem cells - the patent landscape. Intell Prop & Techn Law J 2006;18:1-4.
28. Harris J. The ethical use of human embryonic stem cells in research and therapy. In: Burley JC, Harris J, eds. A Companion to Genethics. Oxford: Blackwell Publishing Limited, 2001:158-174.
29. Hansson MG. Human Dignity & Animal Well-Being: A Kantian Contribution to Biomedical Ethics. Uppsala: Uppsala University, 1991:29-31, 72-74, 158-163.
30. Westerlund L. Life Science Inventions: The Hurdles of Law. Uppsala: Lustu Forlag, 2004.
31. Council of Europe. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on human rights and biomedicine. April 4, 1997; Oviedo, Asturias.